Skip to content

Federico Mingozzi

Federico Mingozzi

Company: Spark Therapeutics

Job title: CSO

Seminars:

Understanding the Current Challenges of Immunogenicity and Re-Dosing in Gene Therapy 9:15 am

Exploring the challenges associated with administering AAV vectors Assessing the need and feasibility of re-dosing with current technologies Understanding the safety of re-dosingRead more

day: Discussion Day

Chair’s Opening Remarks 9:00 am

Read more

day: Discussion Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.